Cambridge Investment Research Advisors, Inc. Ark Genomic Revolution ETF (De Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 93,278 shares of ARKG stock, worth $2.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
93,278
Previous 109,596
14.89%
Holding current value
$2.3 Million
Previous $2.81 Million
21.74%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding ARKG
# of Institutions
285Shares Held
23.3MCall Options Held
2.91MPut Options Held
2.5M-
Goldman Sachs Group Inc New York, NY3.63MShares$89.3 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.48MShares$85.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.79MShares$68.7 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.78MShares$68.5 Million0.01% of portfolio
-
Citigroup Inc1.66MShares$40.8 Million0.02% of portfolio